Conexeu Sciences Inc. (CNXU) vs Polaryx Therapeutics, Inc. Common Stock (PLYX)

A side-by-side comparison of Conexeu Sciences Inc. and Polaryx Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CNXU

Conexeu Sciences Inc.

$92M

$3.45HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT

PLYX

Polaryx Therapeutics, Inc. Common Stock

$104M

$2.08HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

Total return — CNXU vs PLYX

growth of $100 · dividends reinvested · last 1y

CNXU -76.1% (-76.1%/yr)PLYX -47.5% (-47.5%/yr)PLYX compounded faster over this window

CNXU PLYX

Metrics side by side

CNXU is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full CNXU analysis Full PLYX analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.